Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | glucosidase, alpha | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Streptococcus pyogenes serotype M1 | Streptokinase A | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | geminin | 0.0205 | 1 | 1 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 0.9582 | 0.9541 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0041 | 0.13 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0044 | 0.1454 | 0.1518 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0044 | 0.1454 | 1 |
Loa Loa (eye worm) | ICD-1 protein | 0.0042 | 0.1378 | 0.1438 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0147 | 0.6937 | 0.664 |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.8127 | 0.7946 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0033 | 0.0883 | 0.0922 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.2069 | 0.1301 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0041 | 0.13 | 0.3998 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2069 | 0.1301 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0104 | 0.4657 | 0.486 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0044 | 0.1497 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.2069 | 0.1301 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2069 | 0.1301 |
Plasmodium falciparum | basic transcription factor 3b, putative | 0.0042 | 0.1378 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.1454 | 0.9718 |
Leishmania major | basic transcription factor 3a, putative | 0.0042 | 0.1378 | 0.9476 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.1454 | 0.9718 |
Onchocerca volvulus | 0.0114 | 0.5178 | 1 | |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.679 | 0.7087 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.291 | 0.3037 |
Entamoeba histolytica | hypothetical protein | 0.0078 | 0.3252 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0078 | 0.3252 | 0.2598 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0151 | 0.7162 | 0.6887 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2069 | 0.1301 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0044 | 0.1454 | 0.9718 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0104 | 0.4657 | 0.486 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.2069 | 0.216 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0883 | 0.0922 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0197 | 0.9582 | 0.9541 |
Echinococcus granulosus | transcription factor btf3 | 0.0042 | 0.1378 | 0.0543 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0078 | 0.3252 | 0.2598 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0044 | 0.1454 | 0.9718 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0044 | 0.1497 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0078 | 0.3252 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0033 | 0.0883 | 0.0922 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0044 | 0.1454 | 0.1518 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0078 | 0.3252 | 0.2598 |
Loa Loa (eye worm) | hypothetical protein | 0.0104 | 0.4657 | 0.486 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0197 | 0.9582 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0044 | 0.1497 | 1 |
Echinococcus multilocularis | transcription factor btf3 | 0.0042 | 0.1378 | 0.0543 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.679 | 0.7087 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 0.9582 | 0.9541 |
Trypanosoma cruzi | transcription factor btf3, putative | 0.0042 | 0.1378 | 0.9476 |
Trypanosoma brucei | transcription factor BTF3, putative | 0.0042 | 0.1378 | 0.9476 |
Trypanosoma cruzi | transcription factor btf3, putative | 0.0042 | 0.1378 | 0.9476 |
Schistosoma mansoni | hypothetical protein | 0.0078 | 0.3252 | 0.2598 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0042 | 0.1378 | 0.9208 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0104 | 0.4657 | 0.486 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0042 | 0.1378 | 0.9208 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.2069 | 0.216 |
Entamoeba histolytica | hypothetical protein | 0.0042 | 0.1378 | 0.4238 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0044 | 0.1497 | 0.0673 |
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0044 | 0.1454 | 0.9718 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0044 | 0.1454 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0044 | 0.1454 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0071 | 0.291 | 0.2223 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.2069 | 0.1301 |
Echinococcus granulosus | neutral alpha glucosidase AB | 0.0044 | 0.1454 | 0.0626 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0151 | 0.7162 | 0.6887 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0044 | 0.1454 | 0.4473 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0044 | 0.1454 | 0.4473 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0044 | 0.1497 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.679 | 0.7087 |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.8127 | 0.7946 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0044 | 0.1497 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0033 | 0.0883 | 0.0922 |
Entamoeba histolytica | hypothetical protein | 0.0078 | 0.3252 | 1 |
Entamoeba histolytica | transcription factor BTF3, putative | 0.0042 | 0.1378 | 0.4238 |
Schistosoma mansoni | alpha glucosidase | 0.0044 | 0.1454 | 0.0626 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.2069 | 0.1301 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0042 | 0.1378 | 0.9208 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.1454 | 0.9718 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0197 | 0.9582 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.1454 | 0.9718 |
Echinococcus multilocularis | neutral alpha glucosidase AB | 0.0044 | 0.1454 | 0.0626 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0044 | 0.1454 | 0.6437 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0151 | 0.7162 | 0.7474 |
Entamoeba histolytica | hypothetical protein | 0.0078 | 0.3252 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.1454 | 0.9718 |
Schistosoma mansoni | transcription factor btf3 | 0.0042 | 0.1378 | 0.0543 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0071 | 0.291 | 0.3037 |
Trypanosoma brucei | glucosidase, putative | 0.0044 | 0.1454 | 1 |
Brugia malayi | beta-NAC-like protein | 0.0042 | 0.1378 | 0.1438 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0044 | 0.1454 | 0.9718 |
Brugia malayi | hypothetical protein | 0.0078 | 0.3252 | 0.3394 |
Loa Loa (eye worm) | acetyltransferase | 0.0151 | 0.7162 | 0.7474 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 16.238 um | PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1662 (Primary HTS)] | ChEMBL. | No reference |
EC50 (functional) | > 150 um | PUBCHEM_BIOASSAY: Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1902 (Retest at Dose), 1900 (Counter Screen), 1662 (Primary HTS)] | ChEMBL. | No reference |
Potency (functional) | 0.1122 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 0.3548 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 0.3548 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 2.2387 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.9341 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Potency (functional) | 63.0957 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 79.4328 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.